COVID-19: Sales of new corona remedy in Russia: “Coronavir”
Russian pharmacy:
Based on the Japanese influenza drug “Avigan”, sales of a new coronavirus drug have begun.
Coronavir:
In Russia, sales of two types of Russian-made therapeutic agents such as “Coronavir” began on September 21st.
Coronavir costs about 18,000 yen for 50 tablets.
A doctor’s prescription is required for purchase.
Pharmacy manager: (Q. Is it effective?)
It is effective in the early and middle stages of the new corona.
Coronavir is a generic drug of the new influenza drug “Avigan” developed by Fujifilm Toyama Chemical Co., Ltd. of Japan.
A Russian manufacturer commented that “more than half of the patients who received it improved their symptoms within a week.”
https://news.tv-asahi.co.jp/news_international/articles/000193741.html
Russia Health Ministry Allows Use of Favipiravir for Outpatient COVID-19 Use
Back on June 1, TrialSite reported that Russian regulators approved a version of favipiravir known as Avifavir for hospitalized patients.
Now the Russian Healthcare Ministry has approved the use of two favipiravir-based preparations for outpatient treatment for the SARS-CoV-2 indication.
Russi Russian Approvals
Recently, Russia’s Tass shared with the world the update to Favipiravir status in that country.
Russia
has achieved technically two firsts since the onset of pandemic.
In May, the regulators there approved the Favipiravir version called Avifavir making it the world’s first approved therapy targeting COVID-19, according to Tass.
Of course, months later Russia also was the first to actually certify a vaccine, albeit in an unorthodox manner.
a Health Ministry Allows Use of Favipiravir for Outpatient COVID-19 Use